Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery

In 2021, mRNA vaccines against COVID-19 were approved by the Food and Drug Administration. mRNA vaccines are important for preventing severe COVID-19 and returning to normal life. The development of RNA-delivery technology, including mRNA vaccines, has been investigated worldwide for ~30 years. Lipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeki, Masatoshi, Uno, Shuya, Niwa, Ayuka, Okada, Yuto, Tokeshi, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851889/
https://www.ncbi.nlm.nih.gov/pubmed/35183654
http://dx.doi.org/10.1016/j.jconrel.2022.02.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851889/
https://www.ncbi.nlm.nih.gov/pubmed/35183654
http://dx.doi.org/10.1016/j.jconrel.2022.02.017

Ejemplares similares